1. Introduction {#s0005}
===============

Transmissible gastroenteritis virus (TGEV) can infect enteric and respiratory tissues and cause transmissible gastroenteritis (TGE), which is characterized by vomiting, severe diarrhoea and dehydration. At present, TGE continues to be considered internationally as a highly contagious disease in swine, which results in a mortality rate close to 100% in newborn piglets ([@bb0010], [@bb0130]). A common vaccine likely cannot induce a local immune response in the small intestine and provide solid protection to piglets ([@bb0145]). Therefore, the development of effective anti-TGEV agents for controlling TGEV infection remains an important goal.

Green tea is derived from the dried leaves of *Camellia sinensis* and is one of the most commonly consumed beverages around the world ([@bb0100], [@bb0115]). Approximately 70% of green tea extracts is catechins (monomeric flavonoids) ([@bb0120]). (+)-Catechin is one of the catechins in green tea. Many studies have shown that the catechins of green tea possess multiple pharmacological activities ([@bb0015], [@bb0040], [@bb0135]). Previous antiviral studies have indicated that catechins exert inhibitory effects on different types of viruses in different ways ([@bb0040]). Typically, epigallocatechin gallate (EGCG), a subclass of catechins, can efficiently inhibit the entry of hepatitis B virus (HBV) into immortalized human primary hepatocytes by inducing clathrin-dependent endocytosis ([@bb0065]). The antiviral effect of EGCG on human immunodeficiency virus type 1 (HIV-1) has been shown for several steps in the HIV-1 life cycle, including a destructive effect on viral particles, post-adsorption entry and reverse transcription in acutely infected monocytoid cells ([@bb0150]). The antioxidant and anti-inflammatory activities of (+)-catechin have been previously observed in several studies ([@bb0005]). However, the impact of (+)-catechin on viral infections has not been previously investigated in detail.

The present study aimed to investigate the antiviral potential of (+)-catechin. We used a swine testicle (ST) cell line to assess the protective effects of (+)-catechin on TGEV infection in terms of viral replication and cell survival. In addition, the antiviral mechanism of (+)-catechin was preliminarily studied.

2. Materials and methods {#s0010}
========================

2.1. Compounds {#s0015}
--------------

(+)-Catechin was purchased from Shanghai Winherb Medical Technology Co., Ltd. (China). It was dissolved in dimethyl sulfoxide (DMSO) and stored at − 20 °C. MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazoliumbromide), 6-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) and dihydroethidium (DHE) were obtained from Beyotime Institute of Biotechnology (Jiangsu, China).

2.2. Cells and virus {#s0020}
--------------------

Swine testicle (ST) cells were grown in minimal essential medium (MEM; GIBCO, UK) with 10% foetal calf serum (HyClone, China). The TGEV H16 strain was purchased from the National Control Institute of Veterinary Bioproducts and Pharmaceuticals (Beijing, China) and grown in ST cells.

2.3. MTT assay {#s0025}
--------------

The cytotoxicity and antiviral effects were tested using the MTT assay. Different concentrations of compounds were added to ST cell monolayers in 96-well culture plates with or without TGEV absorption. Untreated cells served as the control. All of the cells were maintained at 37 °C in 5% CO~2~. The supernatant was carefully removed from the plate without disturbing the attached cells, and 50 μL of MTT (2 μg/mL) was added to each well. After the plate was incubated at 37 °C for 4 h, the excess MTT was removed, and 200 μL of DMSO was added to each well. The 96-well culture plate was placed in an electronic oscillator for 10 min to dissolve the formazan crystals. The light absorbance of each well was measured at 490 nm in a microplate reader (Thermo).

2.4. Assays of antiviral activity {#s0030}
---------------------------------

To investigate the effect of (+)-catechin on TGEV reproduction, three different assays were performed. First, TGEV and (+)-catechin were mixed and incubated at 4 °C for 1 h, and the mixture was then added to ST cell monolayers in culture plates at 37 °C in 5% CO~2~ for 1 h. After 1 h of adsorption, the unadsorbed virus and compounds were replaced with fresh medium. Second, (+)-catechin was added to ST cells 4 h before TGEV adsorption. The remaining steps were the same as those used in the first assay. Third, TGEV was adsorbed for 1 h at 37 °C in 5% CO~2~. The unadsorbed viruses were removed, and media containing different concentrations of (+)-catechin were added. Mock-treated cells and cells treated with only TGEV served as controls in all of the assays. The cell morphology was observed, and the antiviral effect was analysed after 48 h using the MTT assay. All of the tests were performed in triplicate.

2.5. Virus titration {#s0035}
--------------------

The culture supernatants were collected for virus titration. The supernatants were serially diluted 10-fold from 10^--1.0^ to 10^--11.0^ and added to ST cell monolayers in 96-well culture plates. Each dilution was added to eight wells. The TCID~50~ was calculated by the Karber method after 48 h of infection.

2.6. RNA extraction and quantitative real-time PCR {#s0040}
--------------------------------------------------

ST cells were cultured in six-well culture plates. TGEV was added to the ST cells at 70--80% confluence in the plates, with the exception of the negative control. After 1 h of incubation at 37 °C in 5% CO~2~, the medium was removed, and fresh medium containing (+)-catechin was added. Fresh medium with the same concentration of EDTA was added to the positive-control and negative-control wells. TGEV-infected cells were collected 40 h after viral infection to evaluate the inhibitory effects of (+)-catechin on TGEV replication. RNA extraction, cDNA synthesis and quantitative real-time PCR were performed according to a previous report ([@bb0055]). The Ct method was employed to analyse the data, and the amount of RNA in the samples was normalized to that of β-actin.

2.7. Detection of intracellular reactive oxygen species (ROS) {#s0045}
-------------------------------------------------------------

The intracellular ROS was measured using an oxidation-sensitive fluorescent probe (DCFH-DA). After TGEV infection and (+)-catechin treatment for 24 h, ST cells were washed with PBS and incubated with 10 μM DCFH-DA for 20 min at 37 °C. H~2~O~2~ served as a control. The extracellular DCFH-DA was washed three times with PBS. The fluorescence was observed and recorded using a fluorescence microscope (Nikon, Japan).

The intracellular superoxide anion was measured using a fluorescent dye DHE. TGEV infection and (+)-catechin treatment were the same as those used in the DCFH-DA assay. ST cells were washed with PBS and incubated with 2.5 μM DHE for 30 min at 37 °C. The fluorescence was measured using a luminescence plate reader (Perkin Elmer, America). The light absorbance of each well was measured at 610 nm.

3. Results {#s0050}
==========

3.1. Measurement of cytotoxic (+)-catechin concentrations {#s0055}
---------------------------------------------------------

Before (+)-catechin could be used for antiviral studies, a non-toxic dose was determined by adding different concentrations to ST cells. (+)-Catechin was serially diluted two-fold from 1280 μM to 10 μM. At (+)-catechin concentrations less than 320 μM, there was no difference in the cellular morphology and density between the (+)-catechin-treated and control cells. ST cells treated with 640 μM (+)-catechin presented evident morphological changes, including cell shrinkage, cell size reduction, turning round and shedding.

The (+)-catechin cytotoxic concentration was determined by the MTT assay. Consistent with the morphological observations, no significant difference was obtained at (+)-catechin concentrations less than 320 μM. However, the cell viability observed with 640 μM (+)-catechin was decreased compared with that of the cells treated with (+)-catechin at concentrations less than 320 μM ([Fig. 1](#f0005){ref-type="fig"} ).Fig. 1(+)-Catechin cytotoxicity. Different concentrations of (+)-catechin were added to ST cell monolayers in 96-well plates. The tested concentrations were between 20 and 1280 μM. The MTT assay was used to test the cell viability after 48 h of incubation at 37 °C. The relative cell viability was calculated by comparing the O.D.~490~ values of the (+)-catechin-treated cells with those of the non-treated control cells (set to 100%). The relative cell viability obtained after incubation with different concentrations of (+)-catechin is provided. The cell viability of the cells treated with (+)-catechin at concentrations less than 320 μM was not different from that of the non-treated control cells. The results represent the means ± SD.

According to the test results, we ascertained that a dose of (+)-catechin less than 320 μM was safe.

3.2. Antiviral effect of (+)-catechin {#s0060}
-------------------------------------

After the cytotoxicity test, we tested the antiviral effect of (+)-catechin. To determine which steps in the viral life cycle were affected by (+)-catechin, the antiviral effect was tested through three different approaches. (+)-Catechin was added before, during and after the incubation of ST cells with TGEV. As shown in [Fig. 2](#f0010){ref-type="fig"}A, no difference was found between the virus controls and the samples in which (+)-catechin was added to ST cells before and during TGEV inoculation. However, the cell viability was markedly increased by the addition of (+)-catechin after TGEV incubation. Approximately 93% of ST cells retained a normal viability after (+)-catechin treatment, but 60% of the untreated ST cells were damaged after TGEV infection.Fig. 2(+)-Catechin cytoprotection. (A) The cell viability of TGEV-infected ST cells with different (+)-catechin treatments were measured by the MTT assay. Pretreatment: TGEV were treated with 80 μM (+)-catechin at 4 °C for 1 h prior to viral infection; Competition: ST cells were treated with 80 μM (+)-catechin at 37 °C for 4 h prior to TGEV infection; Post-infection treatment: 80 μM (+)-catechin was added after TGEV infection. The cell protection effect was determined by comparing the O.D.~490~ values of the (+)-catechin-treated cells with those of the non-treated control cells (set to 100%). (B) Different concentrations of (+)-catechin were added to ST cells after TGEV infection. Concentrations less than 320 μM were used. After 48 h of incubation, the cell viability was measured by the MTT assay. The relative cell viabilities were calculated by comparing the O.D.~490~ values of the (+)-catechin-treated TGEV-infected cells with those of the uninfected control cells (set to 100%). The results represent the means ± SD.

3.3. Dose-dependence of antiviral effect of (+)-catechin {#s0065}
--------------------------------------------------------

Different concentrations of (+)-catechin were added to ST cells after TGEV infection. The cell viability was tested by the MTT assay. As shown in [Fig. 2](#f0010){ref-type="fig"}B, 10 μM (+)-catechin exerted an obviously protective effect. At drug concentrations in the range of 20 to 40 μM, the cell survival rate reached almost 90%, whereas at drug concentrations greater than 80 μM, the cell survival rate reached almost 95%. However, the protective effect could not be increased with a further increase in concentration.

3.4. Cytopathic effect of (+)-catechin in TGEV-infected ST cells {#s0070}
----------------------------------------------------------------

TGEV exerts a cytopathic effect (CPE) on ST cells ([Fig. 3](#f0015){ref-type="fig"}A). This CPE was observed by the addition of 20 μM, 40 μM or 80 μM (+)-catechin after TGEV infection. In agreement with the cytopathic observations, (+)-catechin distinctly delayed and alleviated the CPE. ST cells remained attached to the wall and presented a paving stone sample ([Fig. 3](#f0015){ref-type="fig"}C, E and G). In particular, at a concentration of (+)-catechin of 80 μM, the morphology of the (+)-catechin-treated ST cells was almost the same as that of the negative control 48 h after viral inoculation.Fig. 3(+)-Catechin inhibits the cytopathic effect of TGEV (200 ×). (+)-Catechin was added after TGEV absorption for 1 h at 37 °C. Photographic images were collected after 48 h of incubation. (A) TGEV-infected ST cells; (B) ST cells; (C) ST cells treated with 20 μM (+)-catechin after TGEV infection; (D) ST cells treated with 20 μM (+)-catechin; (E) ST cells treated with 40 μM (+)-catechin after TGEV infection; (F) ST cells treated with 40 μM (+)-catechin; (G) ST cells treated with 80 μM (+)-catechin after TGEV infection; and (H) ST cells treated with 80 μM (+)-catechin.

3.5. Inhibition of TGEV replication by (+)-catechin {#s0075}
---------------------------------------------------

### 3.5.1. Effect of (+)-catechin on viral yield in TGEV-infected ST cells {#s0080}

A TCID~50~ assay was used to confirm the anti-TGEV activity of (+)-catechin by measuring the released virus in the medium. (+)-Catechin was added to ST cells after TGEV infection, and the supernatants after 48 h of incubation were collected. As shown in [Fig. 4](#f0020){ref-type="fig"}A, the TCID~50~ of the control was approximately 10^6.0^, whereas the TCID~50~s of the groups treated with 20 μM, 40 μM and 80 μM (+)-catechin were 10^4.5^, 10^4.3^ and 10^3.9^, respectively. The TGEV viral burden in the supernatants treated with 80 μM (+)-catechin was reduced by approximately 237 fold.Fig. 4(+)-Catechin inhibits TGEV proliferation. (A) Less viral production was observed in (+)-catechin-treated cells infected with TGEV. The cells were treated with 20 μM, 40 μM or 80 μM (+)-catechin after TGEV infection. Cell culture supernatants were collected after 48 h of incubation at 37 °C, and the viral titre was determined by TCID~50~. (B) The effect of (+)-catechin on TGEV RNA synthesis was assessed. Cells were treated with 20 μM, 40 μM or 80 μM (+)-catechin after TGEV infection, and cell monolayers were collected by TRIzol after 40 h of incubation. The expression levels of TGEV RNA were measured by quantitative RT-PCR. The (+)-catechin-treated cells presented significant decreases in the TGEV RNA load. The data represent the means ± SD.

### 3.5.2. Effect of (+)-catechin on viral RNA synthesis {#s0085}

To test the inhibitory effect of (+)-catechin on viral RNA synthesis, real-time quantitative RT-PCR was performed. As shown in [Fig. 4](#f0020){ref-type="fig"}B, TGEV RNA synthesis was greatly inhibited by (+)-catechin. The addition of 20 μM (+)-catechin decreased the TGEV RNA levels by more than 3 fold compared with the positive control. The TGEV RNA synthesis was reduced by almost 10 fold by the addition of 80 μM (+)-catechin.

3.6. Alleviation of TGEV infection-induced intracellular ROS by (+)-catechin {#s0090}
----------------------------------------------------------------------------

TGEV infection can cause a ROS explosion ([Fig. 5](#f0025){ref-type="fig"}E), and the ROS levels were approximately the same as the levels observed in cells treated with 100 μM H~2~O~2~ for 24 h ([Fig. 5](#f0025){ref-type="fig"}A). ROS induction by TGEV infection or H~2~O~2~ treatment was greatly down regulated after (+)-catechin treatment ([Fig. 5](#f0025){ref-type="fig"}B--D and F--H). The intracellular ROS levels decreased after treatment with 20 μM (+)-catechin. However, the ROS levels were almost completely suppressed with 80 μM (+)-catechin in both the infected cells and H~2~O~2~-treated cells. No ROS was detected in the non-infected and non-H~2~O~2~-treated cells ([Fig. 5](#f0025){ref-type="fig"}I--L).Fig. 5(+)-Catechin alleviates intracellular ROS (100 ×). The intracellular ROS levels were measured by the fluorescent probe DCFH-DA. After 100 TCID~50~ TGEV infection and (+)-catechin treatment for 24 h, the fluorescence was observed and recorded using a fluorescence microscope. H~2~O~2~ was used as a positive control. (A) ST cells treated with 100 μM H~2~O~2~; (B) ST cells treated with 20 μM (+)-catechin after 100 μM H~2~O~2~ stimulation; (C) ST cells treated with 40 μM (+)-catechin after 100 μM H~2~O~2~ stimulation; (D)ST cells treated with 80 μM (+)-catechin after 100 μM H~2~O~2~ stimulation; (E) TGEV-infected ST cells; (F) ST cells treated with 20 μM (+)-catechin after TGEV infection; (G) ST cells treated with 40 μM (+)-catechin after TGEV infection; (H) ST cells treated with 80 μM (+)-catechin after TGEV infection; (I) ST cells; (J) ST cells treated with 20 μM (+)-catechin; (K) ST cells treated with 40 μM (+)-catechin; and (L) ST cells treated with 80 μM (+)-catechin.

The intracellular superoxide anion induced by TGEV infection was measured using DHE. As shown in [Fig. 6](#f0030){ref-type="fig"} , TGEV infection can cause an obvious up-regulation of intracellular superoxide anion. As expected, superoxide anion induction by TGEV infection was down regulated after (+)-catechin treatment, especially with 80 μM (+)-catechin. No superoxide anion was induced in the non-infected cells.Fig. 6(+)-Catechin alleviates intracellular superoxide anion. The intracellular superoxide anion levels were measured by the fluorescent probe DHE. After 100 TCID~50~ TGEV infection and (+)-catechin treatment for 24 h, the fluorescence was measured using a luminescence plate reader. The relative DHE fluorescence was calculated by comparing the O.D.~610~ values of each treated cells with the non-treated control cells (set to 1). The results represent the means ± SD.

4. Discussion {#s0095}
=============

Catechins, a main ingredient of green tea extracts, have multiple bioactivities. The health care and therapeutic effects of catechins have received great attention, and previous studies have proven that these effects are beneficial ([@bb0075], [@bb0125]). TGEV is one of the major pathogens that causes severe diarrhoea in newborn piglets ([@bb0155]). This study was designed to explore the antiviral effect of catechins in TGEV infection.

Viral infection is a multi-step process involving a number of different cell and viral factors. All viruses rely on host cell proteins and their associated mechanisms to complete the viral life cycle. Viral proliferation can be inhibited regardless of which step in the viral life cycle is been blocked ([@bb0035], [@bb0070]). Many studied have proven that catechins can block viral infectivity by inhibiting viral adsorption and entry ([@bb0065], [@bb0095], [@bb0150]). However, our results showed that (+)-catechin exerts no inhibitory effect on TGEV infection in TGEV or ST cells pretreated with (+)-catechin, suggesting that (+)-catechin has no effect on viral particle integrity and the entry process.

Interestingly, TGEV proliferation can be suppressed by the addition of (+)-catechin after TGEV infection. As shown by our results, the viral RNA loading in infected cells and the viral titre in the supernatant were markedly decreased after (+)-catechin incubation. This result indicates that (+)-catechin may inhibit TGEV replication and/or viral assembly and release, which is consistent with the results obtained in other antiviral studies of green tea catechins. EGCG can down regulate HBV DNA loading in HepG2.2.2.15 cells and the levels of HBsAg and HBeAg secreted from infected cells into the supernatant ([@bb0110]). Epstein--Barr virus spontaneous lytic infection can be restricted at the DNA, gene transcription and protein levels by suppressing the activation of the MEK/ERK1/2 and PI3-K/AKT signalling pathways ([@bb0085]). Hepatitis C virus (HCV) can also be inhibited by EGCG at the RNA replication steps in the HCV life cycle ([@bb0020]). In our study, (+)-catechin showed the same inhibitory effect on viral replication as other green tea catechins.

Oxidative stress is an important pathogenic mechanism that has been implicated in many viral infections, including HCV ([@bb0105]), human immunodeficiency virus (HIV) ([@bb0090]) and classical swine fever virus (CSFV) ([@bb0050]). TGEV induces a CPE in ST cells, and this effect is associated with TGEV-induced apoptosis ([@bb0030]). Furthermore, the ROS response is up regulated in TGEV-infected cells, and ROS accumulation causes oxidative stress, which plays an important role in the TGEV-induced apoptosis pathway ([@bb0025]). Antiviral studies have shown that EGCG decreases the ROS levels in MDCK cells infected by influenza A virus and inhibits influenza A replication ([@bb0080]). In addition, the replication of enterovirus 71 is inhibited by EGCG, which is consistent with the down regulation of ROS generation in infected Vero cells ([@bb0060]). As a natural antioxidant, (+)-catechin can protect human hepatoma cells (HepG2) from oxidative DNA damage induced by heterocyclic amines ([@bb0045]). Additionally, the apoptosis induced by oxidative stress in dermal fibroblasts can be protected by (+)-catechin ([@bb0140]). As shown by our results, (+)-catechin can protect ST cells from TGEV-induced CPE and greatly alleviated the ROS induced by TGEV. In conjunction with the improved intracellular ROS conditions, TGEV RNA replication and the viral titre in the supernatant were clearly down regulated. Hence, the antioxidative activity of (+)-catechin is a key factor in cytoprotection and antiviral activity.

In summary, we demonstrated that (+)-catechin can inhibit TGEV replication in ST cells and that this antiviral activity is related to its antioxidation. This study provides novel findings concerning the antiviral effect of (+)-catechin.
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